Prevalence of Potential Drug-Drug Interactions With Ritonavir-Containing COVID-19 Therapy in the United States: An Analysis of the National Health and Nutrition Examination Survey
Description
PURPOSE: The evolving epidemiology and treatment landscape of COVID-19 necessitates research into potential drug-drug interactions (pDDIs) from the use of new treatments for COVID-19, particularly those that contain ritonavir, a potent inhibitor of
